Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
acute, apolipoprotein, assay, assessment, attention, baseline, battery, case, decision, devote, discernible, downstream, Dr, Emax, emission, employment, endpoint, Eric, Exhibit, exhibited, exposure, fall, feasibility, forgoing, fourth, headache, hemorrhage, hereto, homozygote, hypersensitivity, interaction, investigate, journal, load, LP, maximal, MD, met, month, neurodegeneration, PET, PK, plaque, positron, post, proportional, proportionality, rapid, raw, repeated, revealed, role, RSU, salary, sample, serum, short, show, showed, size, small, stage, statistically, studied, study, SUVr, symptomatic, syndrome, timeline, titer, tomography, treated, unexpected
Removed:
enrollment, February
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view